Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
Sign Up to like & getrecommendations! Published in 2017 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-017-0301-y
Abstract: BackgroundImmunotherapies, specifically those based on immune checkpoint inhibitors, have shown promising activity in multiple tumor types. Other than mifamurtide (MEPACT®) for osteosarcoma approved by European Medicines Agency, there are no approved immunotherapies for sarcomas.MethodsWe analyzed… read more here.
Keywords: patients advanced; immunotherapy trials; checkpoint inhibitors; advanced sarcoma ... See more keywords
Extra-Pleural Pneumonectomy (EPP) in Children and Adults with Locally Advanced Sarcoma: A CanSaRCC Study
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29060340
Abstract: Simple Summary Extra-pleural pneumonectomy (EPP) involves the removal of the parietal and visceral pleura, ipsilateral lungs, pericardium, and hemi diaphragm. In patients with advanced sarcoma in the pleura, EPP is often the only option for… read more here.
Keywords: locally advanced; advanced sarcoma; pleural pneumonectomy; pneumonectomy epp ... See more keywords